Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli

被引:45
|
作者
Deere, J
Iversen, P
Geller, BL
机构
[1] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA
[2] Oregon State Univ, AVI BioPharma, Corvallis, OR USA
关键词
D O I
10.1128/AAC.49.1.249-255.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Phosphorodiamidate morpholino oligomers (PMOs) are synthetic DNA analogs that inhibit gene expression in a sequence-dependent manner. PMOs of various lengths (7 to 20 bases) were tested for inhibition of luciferase expression in Escherichia coli. Shorter PMOs generally inhibited luciferase greater than longer PMOs. Conversely, in bacterial cell-free protein synthesis reactions, longer PMOs inhibited equally or more than shorter PMOs. Overlapping, isometric (10-base) PMOs complementary to the region around the start codon of luciferase inhibited to different extents in bacterial cell-free protein expression reactions. Including the anti-start codon in PMOs was not required for maximal inhibition. PMOs targeted to 5' nontranslated or 3' coding regions within luciferase mRNA did not inhibit, except for one PMO targeted to the ribosome-binding site. Inhibition of luciferase expression correlated negatively with the predicted secondary structure of mRNA regions targeted by PMO but did not correlate with C+G content of targeted regions. The effects of PMO length and position were corroborated by using PMOs (6 to 20 bases) targeted to acpP, a gene required for viability. Because inhibition by PMOs of similar to11 bases was unexpected based on previous results in eukaryotes, we tested an 11-base PMO in HeLa cells and reticulocyte cell-free protein synthesis reactions. The 11-base PMO significantly inhibited luciferase expression in HeLa cells, although less than did a 20-base PMO. In reticulocyte cell-free reactions, there was a trend toward more inhibition with longer PMOs. These studies indicate that strategies for designing PMOs are substantially different for prokaryotic than eukaryotic targets.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 45 条
  • [1] Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers
    Geller, BL
    Deere, JD
    Stein, DA
    Kroeker, AD
    Moulton, HM
    Iversen, PL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) : 3233 - 3239
  • [2] Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture
    Tilley, Lucas D.
    Hine, Orion S.
    Kellogg, Jill A.
    Hassinger, Jed N.
    Weller, Dwight D.
    Iversen, Patrick L.
    Geller, Bruce L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2789 - 2796
  • [3] Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis
    Geller, BL
    Deere, J
    Tilley, L
    Iversen, PL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 983 - 988
  • [4] Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers
    Warfield, Kelly L.
    Swenson, Dana L.
    Olinger, Gene G.
    Nichols, Donald K.
    Pratt, William D.
    Blouch, Robert
    Stein, David A.
    Aman, M. Javad
    Iversen, Patrick L.
    Bavari, Sina
    PLOS PATHOGENS, 2006, 2 (01) : 5 - 13
  • [5] Antisense peptide-phosphorodiamidate morpholino oligomer conjugate:: dose-response in mice infected with Escherichia coli
    Tilley, Lucas D.
    Mellbye, Brett L.
    Puckett, Susan E.
    Iversen, Patrick. L.
    Geller, Bruce L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) : 66 - 73
  • [6] Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo
    Mellbye, Brett L.
    Puckett, Susan E.
    Tilley, Luke D.
    Iversen, Patrick L.
    Geller, Bruce L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 525 - 530
  • [7] Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model
    Hosseini, Alireza
    Lattanzio, Frank A., Jr.
    Samudre, Sandeep S.
    DiSandro, Giovanni
    Sheppard, John D., Jr.
    Williams, Patricia B.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (02) : 194 - 201
  • [8] Inhibition of Intracellular Growth of Salmonella enterica Serovar Typhimurium in Tissue Culture by Antisense Peptide-Phosphorodiamidate Morpholino Oligomer
    Mitev, Georgi M.
    Mellbye, Brett L.
    Iversen, Patrick L.
    Geller, Bruce L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3700 - 3704
  • [9] No Gene-Specific Optimization of Mutation Rate in Escherichia coli
    Chen, Xiaoshu
    Zhang, Jianzhi
    MOLECULAR BIOLOGY AND EVOLUTION, 2013, 30 (07) : 1559 - 1562
  • [10] MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli
    Daly, Seth M.
    Sturge, Carolyn R.
    Felder-Scott, Christina F.
    Geller, Bruce L.
    Greenberg, David E.
    MBIO, 2017, 8 (06):